Prostate Cancer Presenting as Collet-Sicard syndrome
Krishnan, M.; N, B.; K, T.; S, S.
Journal of the Association of Physicians of India 67(8): 72
2019
ISSN/ISBN: 0004-5772 PMID: 31562723 Document Number: 699045
Document emailed within 1 workday
Related Documents
Jiménez-Caballero, P.E.; Marsal-Alonso, C.; Méndez-Cendón, J.C.; Alvarez-Tejerina, A. 2004: Collet-Sicard syndrome secondary to a glomus tumour: evaluation by means of magnetic resonance Revista de Neurologia 39(11): 1072-1073Wakisaka, M.; Takagishi, H. 1994: A case of extremely advanced prostate cancer presenting hemolytic jaundice Hinyokika Kiyo. Acta Urologica Japonica 40(3): 261-263
Papatsoris, A.G.; Mpadra, F.A.; Karamouzis, M.V. 2002: Prostate cancer presenting as a solitary cerebellar metastasis. A case report and review of the literature Tumori 88(1): 61-64
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Nagamatsu, H.; Teishima, J.; Inoue, S.; Hayashi, T.; Matsubara, A. 2016: Prostate cancer and metabolic syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 74(1): 149-154
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Perrin, P.; François, O.; Maquet, J.H.; Bringeon, G.; Duteil, P.; Devonec, M. 1991: Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate Presse Medicale 20(28): 1313-1319
Sharma, S.K.; Handa, R.; Mittal, R.; Saluja, S.; Raghvan, M.V.; Mukhopadhyay, S. 1991: Small cell lung cancer presenting as Cushing's syndrome Indian Journal of Chest Diseases and Allied Sciences 33(2): 91-95
Kochnowski, G.; Rozek, G. 1970: Bronchogenic cancer presenting as Pancoast's syndrome in a patient with pulmonary tuberculosis Wiadomosci Lekarskie 23(13): 1127-1130
Liu, B.-q.; Wu, Y.-d.; Wei, J.-x.; Zhang, T.; Liu, R.-l.; Ma, T.-x. 2007: Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance Zhonghua Nan Ke Xue 13(11): 997-1001
Kelly, W.K. 1998: Endocrine withdrawal syndrome and its relevance to the management of hormone refractory prostate cancer European Urology 34(Suppl): 18-23
Zhu, X-Dong.; Zheng, A.; Wang, Z-Qian.; Shao, Q. 2018: Prostate Cancer Prevention Trial risk calculator for evaluating the risk of prostate cancer in the high-risk Chinese population Zhonghua Nan Ke Xue 24(2): 142-146
Bostwick, D.G. 1994: Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer American Journal of Clinical Pathology 102(4 Suppl 1): S31-S37
Fornara, P.; Sturm, W.; Fabricius, P.G.; Schmiedt, E. 1987: Clinical relevance of radioimmunologic determination of prostate specific antigen in prostate cancer Der Urologe. Ausg. a 26(3): 158-161